Other

Investments Fair Value Disclosure

HCA Healthcare Investments Fair Value Disclosure increased by 20.4% to $124.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.9%, from $107.00M to $124.00M. Over 3 years (FY 2022 to FY 2025), Investments Fair Value Disclosure shows an upward trend with a 3.8% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2022
Last reportedQ1 2026Apr 29, 2026
Metric ID: other_investments_fair_value_disclosure

Historical Data

14 periods
 Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$92.00M$96.00M$99.00M$103.00M$87.00M$95.00M$104.00M$95.00M$88.00M$107.00M$101.00M$94.00M$103.00M$124.00M
QoQ Change—+4.3%+3.1%+4.0%-15.5%+9.2%+9.5%-8.7%-7.4%+21.6%-5.6%-6.9%+9.6%+20.4%
YoY Change————-5.4%-1.0%+5.1%-7.8%+1.1%+12.6%-2.9%-1.1%+17.0%+15.9%
Range$87.00M – $124.00M
CAGR+9.6%
Avg YoY Growth+3.4%
Median YoY Growth+0.1%
Current Streak2 quarters growth

Frequently Asked Questions

What is HCA Healthcare's investments fair value disclosure?
HCA Healthcare (HCA) reported investments fair value disclosure of $124.00M in Q1 2026.
How has HCA Healthcare's investments fair value disclosure changed year-over-year?
HCA Healthcare's investments fair value disclosure increased by 15.9% year-over-year, from $107.00M to $124.00M.
What is the long-term trend for HCA Healthcare's investments fair value disclosure?
Over 3 years (2022 to 2025), HCA Healthcare's investments fair value disclosure has grown at a 3.8% compound annual growth rate (CAGR), from $92.00M to $103.00M.